Breast Cancer Pill Could Reduce The Risk Of Disease
A breast cancer pill called Tamoxifen can reduce the risk of disease. However, General Practitioners were found to be unaware of national guidelines of recommending it to women. Women, thought to be at high risk of having breast cancer because of family history, are supposed to be prescribed with Tamoxifen.
In a survey of 900 General Practitioners, only half know about Tamoxifen. That it could reduce the risk of women having breast cancer. A quarter knew about the guidelines of recommending Tamoxifen for those at high risk. And three-quarters are willing to prescribe it to women at high risk. However, Tamoxifen is not licensed as a breast cancer preventive drug. But General Practitioners are allowed to prescribe an unlicensed drug if upon their examination would be beneficial for the patient. However, they are reluctant to do so.
General Practitioners are concerned that they might be held liable for criticism if the patient experienced side effects. According to the Telegraph, a small survey reported that 500,000 are being denied of this breast cancer pill. However, there is no proof it is true.
The aim of the study was to ask General Practitioners who among them are unaware of the breast cancer pill. And in fact, the 500,000 women at highest risk are the ones that may benefit from taking breast cancer pill, not denied of the pill. The pill is not licensed for preventative use, this is why the General Practitioners are reluctant to prescribe it. And in a study of 42 women taking Tamoxifen over a ten-year time frame, only one breast cancer would be prevented.
According to the NHS, the researchers also found that General Practitioners are more likely comfortable to prescribe medication initiated by the hospital doctors rather prescribing on their own decision. If women are concerned with their breast cancer family history they could probably consult their General Practitioner. And since breast cancer pills are not usually prescribed there are other ways to prevent breast cancer like regular exercise, proper diet and keeping a healthy weight.
Women with Thick Breasts Are More Prone To Having Breast Cancer
Women’s breasts are composed entirely of fat and glandular tissues, but it has now emerged that those with less fat and more tissues could be prone to breast cancer risks – even in the absence of other known risk factors such as family history, having babies after age 30, and genetic mutations among others.
Breast Cancer Causes Father To Get Double Mastectomy
Just because men don't have enlarged breasts doesn't mean they can't have breast cancer. A father becomes the youngest male to undergo double breast removal surgery after both his father and uncle died of the disease.
Breast Cancer Patients Are Not Getting Genetic Testing & Counselling, Doctors 'Never Recommend' It
United States Preventive Services Task Force has emphasized the importance of genetic testing, especially for women with a history of breast cancer in the family. However, a recent study shows only a few actually get their genes tested.
Cancer Rates In Women Set To Rise In The Next 20 Years
A new study predicts the that cancer rates in women will rise six times faster than men. Highlighted as reason for the increased risks are obesity, smoking, and drinking as more women practice unhealthy lifestyles.
Raising Awareness: February 4 Is 'World Cancer Day'; Is The Cure At Hand?
Considering the number of emerging diseases nowadays, how important is it for humanity to understand and become aware of cancer? Why did February 4 become the World Cancer Day? Is there something significant during this day? Get to know what authorities have to reveal.
Breast Cancer Treatment: Could Soy Cure The Disease?
Many US women are not sure if eating soy based food could help them prevent breast cancer. Earlier studies have shown that soy products could help prevent cancer. Soybean-based food are an excellent protein source that is low in calories and saturated fat.
MORE IN ITECHPOST
Ericsson Activates 5G NSA Technology at 5TONIC Open Innovation Lab
Ericsson (NASDAQ: ERIC) together with Telefónica and IMDEA Networks have demonstrated brand-new 5G use cases for Industry 4.0 and Artificial Intelligence (AI) at the European Conference on Networks and Communications (EuCNC) 2019 event held in Valencia, Spain, June 17-21.
Researchers Find New Mutation in the Leptin Gene
San Antonio, Texas (June 19, 2019) - The global obesity epidemic is so far-reaching it now has an overarching name: globesity. Texas Biomed Staff Scientist Raul Bastarrachea, M.D., is part of a team that discovered a new mutation in the gene that regulates the key hormone suppressing hunger called leptin.